Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Feb 24, 2023 8:43pm
152 Views
Post# 35304765

RE:I Like this Company - BUT

RE:I Like this Company - BUT Schocor ...

You got the name right, it's a Goodman company.
You don't buy one of these to play the stock price movement because there isn't any in the early years.
You don't buy it for excitement - because - there isn't any in the early years.
You don't anticipate stock price appreciation because you'll be wrong.

You have to understand this stock is held (the opposite of) widely.

There is only one way to play this company successfully - and even that is boring - but it works.

----------

Remember ... something like 65 people own 70% of the business.
How exciting is that ?
It's a drug reseller with extras - in a foriegn land.
How interesting is that ?
Even having $800 MM in the bank wasn't really exciting for investors.

Fact is ... with this one ... you will wait.  So, what do you do while you wait ?

---------

It's so simple that it isn't of interest to anyone in these early days ... and that's the way I like it.

It isn't that they've upset investors - because they don't have many.
Unsuspecting transients have been hurt ... those who don't understand the business and the approach.

Did they upset hopefuls who thought a bunch of new and exciting things were going to be done with $800 MM?  yes.

So ... this company is right on track.  Perfectly ... on track.  That is very scary to many investors.  They don't understand or care for this business - or - for Goodman.  That's fine as well.

<< Previous
Bullboard Posts
Next >>